Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

JCI will be Gold Open Access starting in 2022

The American Society for Clinical Investigation is pleased to announce that the Journal of Clinical Investigation will be Gold Open Access effective with the Journal’s first issue in 2022.

The ASCI, consistent with its nonprofit mission, has been committed to providing free, immediate access to all research published in the JCI since the journal first appeared online in 1996.1,2 However, non-research content, such as reviews and commentaries, has required a subscription to access.3 Starting in 2022, all content will be freely available and published with the Creative Commons Attribution (CC BY)  license.

With this change, both journals that the ASCI owns and publishes — JCI and JCI Insight — will be Gold Open Access and fully Plan S compliant.

  1. Varki AP. The times they are still a'changing: keeping up with the times. J Clin Invest. 1996;97(1):1.
  2. Hawley JB. The JCI’s commitment to excellence — and free access. J Clin Invest. 2003;112(7):968–969.
  3. Jackson S. Free access to scientific publications: contrasting the JCI approach to Plan S. J Clin Invest. 2019;129(2):440–441.

Published October 28, 2021, by JCI staff

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts